The U.S. the Food and Drug Administration approves Granules India Limited for a replica of AstraZeneca’s medication for heartburn. [Representational image only Credit : Unsplash/] Courtesy : News Agency ; 19/10/2023
Mon. Oct 12th, 2026
The U.S. the Food and Drug Administration approves Granules India Limited for a replica of AstraZeneca’s medication for heartburn. [Representational image only Credit : Unsplash/] Courtesy : News Agency ; 19/10/2023
